| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 08/10/2011 | EP2352724A2 Aryl guanidine f1f0-atpase inhibitors and related methods |
| 08/10/2011 | EP2352723A2 Halogen-substituted compounds used as pesticides |
| 08/10/2011 | EP2203431B1 Anti-infective pyrimidines and uses thereof |
| 08/10/2011 | EP1466907B1 Process for producing quinazolin-4-one and derivative thereof |
| 08/10/2011 | EP1421069B1 Process for the preparation of cyclopenta[g]quinazoline derivatives |
| 08/10/2011 | CN1972940B Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as CRF antagonists |
| 08/10/2011 | CN102149681A Piperazine derivatives for binding and imaging amyloid plaques and their use |
| 08/10/2011 | CN102146096A Aniline quinazoline compound as well as preparation method and application thereof |
| 08/10/2011 | CN102146076A Novel anilinoquinazoline derivatives and preparation method thereof |
| 08/10/2011 | CN102146060A Method for preparing gefitinib and intermediate thereof |
| 08/10/2011 | CN102146059A Quinazoline derivatives and preparation method and application thereof |
| 08/10/2011 | CN101668748B Substituted pyrimidine ether compounds and their use |
| 08/10/2011 | CN101585814B Aryl pyrimidine ortho-single halogen substituted compound and synthetic method thereof |
| 08/09/2011 | US7994318 Coumarin derivatives useful as TNFα inhibitors |
| 08/09/2011 | US7994183 Solid preparation comprising 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-4-fluorobenzonitrile |
| 08/09/2011 | US7994182 Quinazolinone-derivatives and their use for preparation of pharmaceutical compositions having PARP enzyme inhibitory effect |
| 08/09/2011 | US7994167 Pentafluorosulphanyl-substituted compound and its use for producing medicaments |
| 08/09/2011 | US7994093 Heterocyclocarboxamide derivatives |
| 08/09/2011 | CA2731346A1 Compounds for the treatment of lysosomal storage diseases |
| 08/09/2011 | CA2617991C N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof |
| 08/09/2011 | CA2584246C Crystalline forms of 3-[5-chloro-4-[(2,4-difluorobenzyl)oxy]-6-oxopyrimidin-1(6h)-yl]-n-(2-hydroxyethyl)-4-methylbenzamide |
| 08/09/2011 | CA2520027C 2,3,6-trisubstituted-4-pyrimidone derivatives |
| 08/09/2011 | CA2431083C Inflammatory cytokine release inhibitor |
| 08/04/2011 | WO2011092695A1 Quinazoline-based t cell proliferation inhibitors |
| 08/04/2011 | WO2011092611A1 Aminocyclohexanes and aminotetrahydropyrans and related compounds as gamma-secretase modulators |
| 08/04/2011 | WO2011092198A1 5-alkynyl-pyrimidines |
| 08/04/2011 | WO2010108856A8 Leukotriene b4 inhibitors |
| 08/04/2011 | US20110190499 Selective synthesis of functionalized pyrimidines |
| 08/04/2011 | US20110190498 Stereo-specific hydroxylation |
| 08/04/2011 | US20110190295 Compositions and methods for inhibition of hepatocyte growth factor receptor c-met signaling |
| 08/04/2011 | US20110190293 Quinazolinone Compounds as Anticancer Agents |
| 08/04/2011 | US20110190283 Fab I Inhibitors |
| 08/04/2011 | US20110190261 MAPK/ERK Kinase Inhibitors |
| 08/04/2011 | US20110190259 Compounds and compositions as protein kinase inhibitors |
| 08/04/2011 | US20110190211 Cyclopentaquinazoline derivatives for the treatment of rheumatoid arthritis or acute myeloid leukaemia |
| 08/04/2011 | US20110189243 Pharmaceutical formulation for lowering pulmonary blood pressure |
| 08/04/2011 | US20110186821 Azapyrenes for electronic applications |
| 08/04/2011 | CA2787784A1 Small molecules for the modulation of mcl-1 and methods of modulating cell death, cell division, cell differentiation and methods of treating disorders |
| 08/04/2011 | CA2787407A1 5-alkynyl-pyrimidines |
| 08/04/2011 | CA2786688A1 Aminocyclohexanes and aminotetrahydropyrans and related compounds as gamma-secretase modulators |
| 08/03/2011 | EP2351741A1 Pentacyclic liquid crystal compound having nitrogen-containing heterocyclic ring, liquid crystal composition, and liquid crystal display element |
| 08/03/2011 | EP2351731A1 A group of amino substituted benzoyl derivatives and their preparation and their use |
| 08/03/2011 | EP2350030A1 Isoxazole/isoxazoline/combretastatin linked dihydroquinazolinone hybrids as potential anticancer agents and process for the preparation thereof |
| 08/03/2011 | EP2350029A1 3-hydroquinazolin-4-one derivatives for use as stearoyl coa desaturase inhibitors |
| 08/03/2011 | EP2350028A1 Hplc method for the analysis of bosentan and related substances and use of these substances as reference standards and markers |
| 08/03/2011 | EP2350027A1 Tri-substituted pyrimidine compounds and their use as pde10 inhibitors |
| 08/03/2011 | EP2350026A1 Sulfoximine-substituted anilinopyrimidine derivatives as cdk inhibitors, the production thereof, and use as medicine |
| 08/03/2011 | EP2350025A1 An improved process for preparing pyrimidine propenaldehyde |
| 08/03/2011 | EP2350024A2 Improved process for the preparation of endothelin receptor antagonists |
| 08/03/2011 | EP2350023A1 6-phenyl-pyrimidin-4-yl-(phenylamine or phenoxy) derivatives useful as modulators of nicotinic acetylcholine receptors |
| 08/03/2011 | EP2350000A1 Piperazine derivatives for binding and imaging amyloid plaques and their use |
| 08/03/2011 | EP2132185B1 Pyrimidinyl-piperazines useful as dopamine d3/d2 receptor ligands |
| 08/03/2011 | EP1819683B1 Potassium salt of an hiv integrase inhibitor |
| 08/03/2011 | EP1490368B1 2,2-bis(hydroxymethyl)cyclopropylidenemethyl - purines and -pyrimidines as antiviral agents |
| 08/03/2011 | CN1890218B Tubulin inhibitors |
| 08/03/2011 | CN1875002B Phenyl derivatives as PPAR agonists |
| 08/03/2011 | CN1720238B Neurologically-active compounds |
| 08/03/2011 | CN102143951A Tri-substituted pyrimidine compounds and their use as PDE10 inhibitors |
| 08/03/2011 | CN102143750A Macrocyclics pyrimidines as aurora kinase inhibitors |
| 08/03/2011 | CN102143688A 4-alkyl-substituted diaminopyrimidines |
| 08/03/2011 | CN102140090A Dipeptidyl peptidase inhibitors |
| 08/03/2011 | CN101218210B Processes for the manufacture of rosuvastatin and intermediates |
| 08/02/2011 | US7989660 Bactericide against gramnegative bacteria; respiaratory system disorders |
| 08/02/2011 | US7989477 Monocyclic heterocycles as kinase inhibitors |
| 08/02/2011 | US7989464 mGluR1 antagonists as therapeutic agents |
| 08/02/2011 | US7989462 4-arylamin-or-4-heteroarylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 08/02/2011 | US7989459 Purinones and 1H-imidazopyridinones as PKC-theta inhibitors |
| 08/02/2011 | US7989458 Pyrimidine derivatives as alk-5 inhibitors |
| 08/02/2011 | US7989457 Used to treat diabetic and other glucagon related metabolic disorders such as obesity, hyperglycemia, atherosclerosis, ischemic heart disease, stroke, neuropathy, and wound healing; (R,S)-Methanesulfonic acid 2-(3-methyl-4'-trifluoromethyl-biphenyl-4-yl)-propyl ester |
| 08/02/2011 | CA2489209C New derivatives of arylsulfonamides and use thereof in therapy |
| 07/28/2011 | WO2011091213A2 Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof |
| 07/28/2011 | WO2011090323A2 Novel preparation method of 2-(2-n-butyl-4-hydroxy-6-methyl-pyrimidin-5-yl)-n,n-dimethylacetamide |
| 07/28/2011 | US20110184172 Process for the preparation of methyl ester of rosuvastatin |
| 07/28/2011 | US20110183957 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| 07/28/2011 | CA2787756A1 Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof |
| 07/28/2011 | CA2783624A1 Heteroaryl compounds and uses thereof |
| 07/27/2011 | EP2348020A1 Preparation process of erlotinib |
| 07/27/2011 | EP2346837A1 Methods of preparing quinazolinone derivatives |
| 07/27/2011 | EP2346830A1 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
| 07/27/2011 | EP2346825A2 Modulators of p2x3 receptor activity |
| 07/27/2011 | EP1992622B1 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2- methylaminoquinazoline derivative |
| 07/27/2011 | EP1948617B1 Pyrimidinones as casein kinase ii (ck2) modulators |
| 07/27/2011 | EP1638964B1 Novel compounds that modulate ppar-gamma type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 07/27/2011 | EP1419152B1 Hiv inhibiting pyrimidines derivatives |
| 07/27/2011 | CN1930139B Derivatives of hydroxamic acid as metalloproteinase inhibitors |
| 07/27/2011 | CN102137848A 2,4-diaminopyrimidine compound |
| 07/27/2011 | CN102137841A Ortho-substituted haloalkylsulfonanilide derivative and herbicide |
| 07/27/2011 | CN102134231A Dipeptidyl peptidase inhibitors |
| 07/27/2011 | CN102134230A Dipeptidyl peptidase inhibitors |
| 07/27/2011 | CN102134229A Dipeptidyl peptidase inhibitors |
| 07/27/2011 | CN102134223A Preparation and application of novel chiral 3,4-dihydro-2-alkoxyl-6-benzyl-4-oxopyrimidine (S-DABO) human immunodeficiency virus (HIV)-1 reverse transcriptase inhibitor |
| 07/27/2011 | CN102134176A Novel method for preparing aromatic amine through halogenated aromatic hydrocarbon |
| 07/27/2011 | CN101824001B Synthetic method of S-thymine-L-cysteine ester hydrochloride |
| 07/27/2011 | CN101696193B 2-substituted methyl-3-phenyl-acrylic ester compounds with fungicidal activities and preparation method thereof |
| 07/27/2011 | CN101575319B Process for preparing lapatinib synthetic intermediate |
| 07/27/2011 | CN101565405B Sulfamethazine antigen, preparation method and application thereof |
| 07/27/2011 | CN101541766B Pyrimidyl derivatives as protein kinase inhibitors |
| 07/27/2011 | CN101538254B Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and therapeutic use |
| 07/27/2011 | CN101472900B Therapeutic or prophylactic agent for multiple sclerosis |
| 07/27/2011 | CN101273034B Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by VLA-4 |